We are live on ! Find out more
JAG

Journey Advisory Group Portfolio holdings

AUM $1.17B
1-Year Est. Return 20.21%
This Fund
S&P 500
This Quarter Est. Return
+6.35%
1 Year Est. Return
+20.21%
3 Year Est. Return
+58.66%
5 Year Est. Return
+76.52%
10 Year Est. Return
AUM
$315M
AUM Growth
+$28.9M
Cap. Flow
+$12M
Cap. Flow %
3.83%
Top 10 Hldgs %
33.74%
Holding
205
New
11
Increased
89
Reduced
61
Closed
4

Sector Composition

1 Technology 16.2%
2 Healthcare 9.91%
3 Consumer Staples 7.95%
4 Financials 7.81%
5 Industrials 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
26
Berkshire Hathaway Class B
BRK.B
$1.06T
$3.2M 1.02%
11,505
-111
-1% -$31K
RSP icon
27
Invesco S&P 500 Equal Weight ETF
RSP
$96.4B
$3.19M 1.01%
21,171
-2,058
-9% -$306K
EW icon
28
Edwards Lifesciences
EW
$49.4B
$3.03M 0.96%
29,249
-90
-0.3% -$8.48K
SCHR
29
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$2.85M 0.9%
100,044
+580
+0.6% +$16.5K
HUM icon
30
Humana
HUM
$48B
$2.76M 0.88%
6,225
-25
-0.4% -$10.9K
SLV icon
31
iShares Silver Trust
SLV
$27.1B
$2.75M 0.87%
113,360
-900
-0.8% -$22.3K
IBB icon
32
iShares Biotechnology ETF
IBB
$9.23B
$2.47M 0.79%
15,120
-219
-1% -$33.7K
AMT icon
33
American Tower
AMT
$79.2B
$2.46M 0.78%
9,097
+7,947
+691% +$2.03M
CCI icon
34
Crown Castle
CCI
$34.6B
$2.38M 0.76%
12,218
+726
+6% +$136K
FDX icon
35
FedEx
FDX
$74.7B
$2.32M 0.74%
7,772
-125
-2% -$37.1K
XOM icon
36
ExxonMobil
XOM
$611B
$2.28M 0.72%
36,128
+500
+1% +$29.9K
DUK icon
37
Duke Energy
DUK
$97.5B
$2.22M 0.7%
22,454
-248
-1% -$24.9K
CB icon
38
Chubb
CB
$137B
$2.19M 0.69%
13,763
-300
-2% -$49.7K
PFE icon
39
Pfizer
PFE
$143B
$2.17M 0.69%
55,442
+771
+1% +$30K
GOOGL icon
40
Alphabet (Google) Class A
GOOGL
$4.23T
$2.13M 0.68%
17,460
+640
+4% +$74.8K
BRK.A icon
41
Berkshire Hathaway Class A
BRK.A
$1.06T
$2.09M 0.66%
5
VZ icon
42
Verizon
VZ
$182B
$2.02M 0.64%
36,078
+1,100
+3% +$63.1K
PGX icon
43
Invesco Preferred ETF
PGX
$3.91B
$2M 0.64%
130,734
-15,638
-11% -$236K
MRK icon
44
Merck
MRK
$315B
$1.99M 0.63%
25,623
-1,172
-4% -$87.2K
CSX icon
45
CSX Corp
CSX
$94.3B
$1.96M 0.62%
61,011
NOC icon
46
Northrop Grumman
NOC
$74.1B
$1.95M 0.62%
5,354
-100
-2% -$36K
ABBV icon
47
AbbVie
ABBV
$450B
$1.9M 0.6%
16,906
+1,445
+9% +$163K
NVDA icon
48
NVIDIA
NVDA
$4.91T
$1.85M 0.59%
92,720
+2,840
+3% +$45.5K
PSA icon
49
Public Storage
PSA
$55.8B
$1.8M 0.57%
5,973
-75
-1% -$21K
COR
50
DELISTED
Coresite Realty Corporation
COR
$1.78M 0.57%
13,263
-50
-0.4% -$6.25K

Similar funds

Journey Advisory Group's Q2 2021 Portfolio in Review

As of Q2 2021, Journey Advisory Group held 205 positions worth $315M, up 10% from $286M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Journey Advisory Group deployed $12M of net new capital in Q2 2021, opening 11 new positions and adding to 89 existing holdings. Its largest new stake was FMC: 2,643 shares worth $286K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $534K trimmed.

  • Journey Advisory Group's largest Q2 2021 buy was FMC: 2,643 shares worth $286K.
  • Journey Advisory Group added most to American Tower in Q2 2021, an estimated $2.03M increase.
  • Journey Advisory Group's biggest Q2 2021 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $534K.
  • Journey Advisory Group fully exited Clorox in Q2 2021, selling an estimated $1.69M.
  • Journey Advisory Group's ten largest holdings make up 34% of its $315M portfolio in Q2 2021.
  • Journey Advisory Group opened 11 new positions and closed 4 in Q2 2021.
  • Journey Advisory Group's portfolio value rose 10% quarter-over-quarter to $315M.

Based on Journey Advisory Group's 13F filing for Q2 2021, filed 13 Aug 2021.